[1] |
HOU Xiaoyu, LENG Yufang, CAO Xuefen, LV Xingjiao, HAN Xiaoxia, Janvier NIBARUTA, LIU Yongqiang.
Network analysis and experimental verification of Schisandrin B reduces intestinal ischemia reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 147-154.
|
[2] |
SHAO Mingkun, LIU Rong, SUN Pin, GUAN Shui, LIAO Bingcan, LI Sha, CONG Tao, LIANG Kai, MA Hui, SUN Changkai.
Human body networks mechanisms of melatonin and its clinical applications
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1031-1040.
|
[3] |
HUA Haiyan, YAN Jie, QIN Yufen.
Experimental study of schisandrin B attenuates acute myocardial ischemia injury in rats by inhibiting cardiomyocyte apoptosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 848-856.
|
[4] |
LI Xueheng, LI Long.
Research progress on the relationship between melatonin and idiopathic pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 715-720.
|
[5] |
LV Xingjiao, LENG Yufang, HAN Xiaoxia, HOU Xiaoyu, CAO Xuefen, Janvier NIBARUTA, LIU Yongqiang .
Research progress of short-chain fatty acids in alleviating organ ischemia-reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 219-226.
|
[6] |
WANG Rui, PAN Jinjin, LI Hua, YUAN Yuhui.
Research progress of melatonin on pulmonary hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 444-448.
|
[7] |
ZHANG Gaojiao, WANG Xinxin, ZHOU Jia, WANG Leilei, DAI Qinxue.
Ginsenoside Rb1 protects brain through Cav-1 for mice with cerebral ischemia-reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(3): 265-270.
|
[8] |
CUI Haiju, MA Zhangqing, YANG Kui, WANG Wusan, XU Huifang, LUAN Jiajie.
Chronopharmacokinetics of melatonin in non-dipper spontaneous hypertension rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1337-1343.
|
[9] |
ZHANG Chenhan, NIE Jingyun, XIN Pengfei, CHAI Chen, LI Bo.
Research progress of melatonin and pancreatic diseases#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(11): 1309-1314.
|
[10] |
WU Juan, ZHANG He, FENG Guilin.
Agkistrodon halys venom platelet inhibitor inhibits GPVI expression and changes hemorheology in rats with acute myocardial ischemia reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(1): 49-54.
|
[11] |
CHEN Chaohu, ZHUANG Hua, YAO Zhiqiang, HAN Dali, CHANG Cheng, MA Zhongyi, KONG Xiangbing, CAO Jinlong, LI Pan, TIAN Junqiang.
Sodium calcium exchanger and renal ischemia reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(3): 355-360.
|
[12] |
YU Han, ZHONG Xianggen, LI Yunzhou, XU Zongying, SHI Shaohua, DENG Xiulan.
Effects of melatonin on NO, MDA, GSH and NADPH expression in liver tissues of intrahepatic cholestasis rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(11): 1221-1226.
|
[13] |
SONG Juan, TIAN Xiaoxia, LI Baohong, WANG Dong, MENG Dongchao, LU Yanzhen.
Effect and mechanism of resveratrol alleviates hepatic ischemia reperfusion injury by HMGB1 in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1215-1220.
|
[14] |
FAN Kaiyu,WANG Bing,MEI Xiaole,CHEN Zhiwu.
Protective effects of total flavonoids of Chuzhou chrysanthemum against cerebral ischemia- reperfusion injury in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 9-12.
|
[15] |
XU Lin, ZHANG Deng-wen, YANG Shi-jie, TIAN Xue-bi, WANG Yu, HAN Ai-di, ZHANG Chuan-han, TIAN Yu-ke, WANG Xue-ren.
Effect of remote ischemic preconditioning on the expression of myocardial ATP-sensitive potassium channel
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(4): 366-369.
|